Use access key #2 to skip to page content.
$49.45 -0.44 (-0.88%)
10/10/2008 4:01 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

View All Commentary (ABT)

Recs

6

Avatar TMFHelical (99.49) Submitted: 6/15/06 4:45 AM : Outperform Start Price: $41.07 ABT Score: 49.05

I believe medical diagnostics, specifically clinically validated test products is the next great growth area for biotechnology. ABT is a leader in this area, second only to Roche. In addition to the diagnostics, there is a solid pharmaceutical business. I like the size and growth of the dividend payout.

Negative is a government investigation into Medicare billing practices and as with all pharma - pipeline concerns.

Report this Post Replies: 0 | Reply

Featured Broker Partners